| 摘要 |
The present invention relates to the combination of an antipsychotic agent selected from D2 receptor antagonists, partial agonists, or inverse agonists, and a glycine transporter type 1 (GlyT-1) inhibitor. Accordingly, the present invention relates to the treatment of patients with schizophrenia, in particular treatment of patients with positive symptoms and negative symptoms, and cognitive impairment in patients with schizophrenia. |
| 申请人 |
H. LUNDBECK A/S;JOERGENSEN, STEFFEN, WAD;DAHL, ALLAN, CARSTEN;DIDRIKSEN, MICHAEL;LARSEN, FRANK;WAERNER, TORBJOERN;SOEBY, KARINA, KROEJER;TOFT, DORTHE, BACH;HELBOE, THOMAS |
发明人 |
JOERGENSEN, STEFFEN, WAD;DAHL, ALLAN, CARSTEN;DIDRIKSEN, MICHAEL;LARSEN, FRANK;WAERNER, TORBJOERN;SOEBY, KARINA, KROEJER;TOFT, DORTHE, BACH;HELBOE, THOMAS |
